Key Points for Consumers: Biotech Act I

Biotechnologies like vaccines, gene-therapies, or alcoholic fermentation in bread to enhance flavours are increasingly shaping Europe’s health and food systems, directly affecting patients and consumers. Innovation and competitiveness matter but must never compromise safety or public trust. Simplification must ensure rigorous risk assessment, and respect for the precautionary principle. Transparency and clear safeguards are essential to ensure innovation serves the public interest.